Yishen Qutong Simulant Granules

DRUG2 trials

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, LI FENG

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)Extensive-stage Small Cell Lung Cancer (SCLC)

Unknown Phase

A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC

Enrolling by invitationNCT06863831

Cancer Institute and Hospital, Chinese Academy of Medical SciencesEsophageal Squamous Cell Carcinoma (ESCC)

Start: 2024-08-22End: 2027-10-31Target: 536Updated: 2025-03-07

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

Enrolling by invitationNCT07390565

LI FENGExtensive-stage Small Cell Lung Cancer (SCLC)

Start: 2026-02-17End: 2028-06-30Target: 308Updated: 2026-02-09